This study further extends our understanding of molecular mechanisms underlying dystonia, and establishes a new functional paradigm to evaluate the inhibitor of ER stress to compensate for mutant Tor1a, which may be beneficial for neuronal function. The gene discussed is TOR1A; the disease is Dystonia.